22157.jpg
RNAi Market and Technologies Industry Report 2024, with Company Profiles of Major Players including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity
August 23, 2024 04:02 ET | Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for RNAi technology is estimated to...
Global MiRNA Sequencing and Assay Market
miRNA Sequencing and Assay Market Review 2019-2023 and Forecast 2024-2029: miRNA Technologies Spearhead Custom-Tailored Therapies for Individualized Treatment
May 02, 2024 09:12 ET | Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
22157.jpg
microRNA (miRNA) Global Strategic Business Report 2024-2030: Increasing Investments and Focus on Development of miRNA-based Therapeutics Bodes Well for Market Growth
April 18, 2024 07:16 ET | Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global microRNA (miRNA) Market to...
Global RNAi Therapeutics Market
RNAi Therapeutics Market Global Industry Analysis and Forecasts to 2030: A $20.23 Billion Market in 2030, with a CAGR of a 7.69% During 2023-2030
January 17, 2024 12:03 ET | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030" report has been added to ResearchAndMarkets.com's...
microRNA (miRNA) Market
Global microRNA (miRNA) Strategic Research Report 2023: Market to Reach $840.8 Million by 2030 from $282.6 Million in 2022 - Increasing Investments in miRNA to Bolster Market Growth
January 08, 2024 12:18 ET | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global microRNA (miRNA) Market to...
Global MicroRNA Market
MicroRNA Research Report 2023: Novel Applications at the Forefront of Innovations and Market Opportunities - Global Forecasts to 2030
September 18, 2023 05:28 ET | Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Profiling, Localization, & Quantification), By Application...
Global Market for microRNA (miRNA)
microRNA (miRNA) Global Market is Projected to Reach $840.8 Billion by 2030: Increasing Demand for Liquid Biopsies to Drive Growth
June 30, 2023 05:03 ET | Research and Markets
Dublin, June 30, 2023 (GLOBE NEWSWIRE) -- The "microRNA (miRNA): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for microRNA (miRNA)...
Global RNAi Therapeutics Market
Global RNAi Therapeutics Market 2023 to 2027: Featuring Sanofi, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma and Sirnaomics
March 16, 2023 05:38 ET | Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
mirna-tools-and-services-market-share.jpg
Global miRNA Tools and Services Market Report 2022: Featuring GE, Thermo Fisher, Bio-Rad Laboratories, Promega & More
December 02, 2022 07:38 ET | Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Global miRNA Tools and Services Market Size, Share & Industry Trends Analysis Report by Technology (qRT-PCR, Extraction Tools, NGS, Microarray,...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual Meeting
October 20, 2022 16:28 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...